Scarica l'app Stockscreener
3.20
0.00%
0.00
Voyager Therapeutics Inc Borsa (VYGR) Ultime notizie
Financial Comparison: Prime Medicine (NYSE:PRME) & Voyager Therapeutics (NASDAQ:VYGR) - Defense World
Voyager Therapeutics at H.C. Wainwright: Genetic Innovation in Focus By Investing.com - Investing.com Canada
Equities Analysts Offer Predictions for VYGR FY2026 Earnings - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspecti - GuruFocus
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference | VYGR Stock News - GuruFocus
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewswire
Millennium Management LLC Sells 60,935 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Squarepoint Ops LLC Decreases Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade) - Seeking Alpha
Voyager Therapeutics Approves Stock Plans at Annual Meeting - TipRanks
BNP Paribas Financial Markets Sells 43,210 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Holdings Lowered by ProShare Advisors LLC - Defense World
Deutsche Bank AG Cuts Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Jane Street Group LLC - Defense World
Voyager Therapeutics stock plunges to 52-week low of $2.71 By Investing.com - Investing.com South Africa
Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates - MSN
Voyager Therapeutics stock plunges to 52-week low of $2.71 - Investing.com
It's Unlikely That The CEO Of Voyager Therapeutics, Inc. (NASDAQ:VYGR) Will See A Huge Pay Rise This Year - simplywall.st
Northern Trust Corp Raises Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
With 46% ownership, Voyager Therapeutics, Inc. (NASDAQ:VYGR) has piqued the interest of institutional investors - Yahoo Finance
Cubist Systematic Strategies LLC Buys New Shares in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Tower Research Capital LLC TRC Increases Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Brokerages - Defense World
Voyager Therapeutics (VYGR) Showcases Breakthrough in Gene Thera - GuruFocus
Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain - GlobeNewswire
Revolutionary Brain Drug Delivery: Voyager's New Gene Therapy Shows 400x Improvement in Landmark Research - Stock Titan
Voyager reports breakthrough in brain drug delivery - Investing.com
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Voyager Therapeutics (VYGR) and Privia Health Group (PRVA) - The Globe and Mail
Q2 EPS Forecast for Voyager Therapeutics Reduced by Analyst - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock Position Increased by Dimensional Fund Advisors LP - Defense World
FY2025 EPS Estimates for VYGR Increased by Cantor Fitzgerald - Defense World
Leerink Partnrs Has Negative Outlook of VYGR Q2 Earnings - Defense World
Q2 EPS Estimates for Voyager Therapeutics Lifted by Wedbush - Defense World
Voyager Therapeutics Reports Q1 2025 Financial Results - TipRanks
Barclays PLC Buys 10,328 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Analysts Have Conflicting Sentiments on These Healthcare Companies: Omnicell (OMCL), Voyager Therapeutics (VYGR) and Masimo (MASI) - The Globe and Mail
Voyager Therapeutics Inc earnings missed by $0.08, revenue fell short of estimates - Investing.com India
Raymond James Financial Inc. Takes $746,000 Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics: Q1 Earnings Snapshot - Connecticut Post
Voyager Reports First Quarter 2025 Financial and Operating Results - The Manila Times
Voyager Therapeutics Q1 2025 Financial and Operating Results - TradingView
Voyager Therapeutics, Inc. SEC 10-Q Report - TradingView
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Renaissance Technologies LLC - Defense World
Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer - Stock Titan
BlackRock, Inc. Reduces Stake in Voyager Therapeutics Inc - GuruFocus
0.34%
7.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):